Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
April 27, 2021
Patent Application Number
16037612
Date Filed
July 17, 2018
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention provides, in part, formulations comprising an alkaline phosphatase (AP)-based agent. Particularly, modified-release powder formulations comprising an AP-based agent are provided which release a substantial amount of the AP-based agent in the intestines. Therapeutic uses of the formulations are also provided.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
